In an interview with Good Morning America, Alison Edelman, M.D., shares how ongoing legal efforts to ban Mifepristone, the most commonly used medication to end early pregnancy, have affected reproductive health providers and delivery of care: “It’s been a huge impact to have our work criminalized, basically, and not allow us to provide the care for the patient in front of us that we know is what’s best for them.”

The Lund Report covers closure of an in-house midwifery unit at McKenzie-Willamette Medical Center in Springfield, noting that OHSU is among other hospitals statewide that integrate certified nurse midwives into their labor and delivery centers.

Healio Pulmonology interviews Akram Kahn, M.D., regarding new clinical practice guidelines to manage respiratory issues in patients with neuromuscular weakness. He says, “Neuromuscular disorders are relatively rare, and an individual physician or other providers may not see many of these patients regularly. This guideline allows providers to assess their management plan against expert recommendations and best use available local resources.”

Radiology Business covers a new study led by Jeff Gold, M.D., that found shortcomings in electronic health records appear to be a contributing factor leading to diagnostic errors in radiology. He says, “These results highlight the importance of the continued work needed to optimize EHR design, interoperability, training and safety surveillance to reduce diagnostic errors.”

Charles Fennell is interviewed by KOIN regarding recruitment for a clinical trial testing a monoclonal antibody to prevent the onset of symptoms of Alzheimer’s disease, especially among people of color who are disproportionately impacted by the disease. He says, “Black people, indigenous people, people of color experience Alzheimer’s up to two times more than white people, so we’re looking for people at high risk for Alzheimer’s disease.”

Researchers have created the largest atlas of post-zygotic mutations in healthy human tissue ever assembled, in a study published in the journal Science. Senior author Don Conrad, Ph.D., says, “If you’re talking about genetic changes being the basis of disease, there are a wide variety of technologies now that allow us to make changes to the genome. It may be possible to change those mutations we’ve acquired due to bad luck or bad habits."

Researchers have created the largest atlas of post-zygotic mutations in healthy human tissue ever assembled, in a study published in the journal Science. Senior author Don Conrad, Ph.D., says, “If you’re talking about genetic changes being the basis of disease, there are a wide variety of technologies now that allow us to make changes to the genome. It may be possible to change those mutations we’ve acquired due to bad luck or bad habits.”

Paul Yang. M.D., Ph.D., discusses a Phase 1/2 clinical trial evaluating a potential gene therapy for a form of Leber congenital amaurosis, an inherited condition that causes severe vision impairment.

A press release noting Oregon is one of three states where proposed legislation would further protect gender-affirming care notes Christina Milano, M.D., testified before the Oregon Legislature about the importance of making gender-affirming health care accessible.

The Food and Drug Administration authorizes marketing for new treatment of osteoarthritis of the knee, based on nationwide clinical trials, including at OHSU. Dennis Crawford, M.D., says, “Quite frankly, there hasn’t been a substantial development for the treatment of this ubiquitous disease for more than 50 years."